As of 2025-09-18, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 15.4x | 11.3x |
| Forward P/E multiples | 10.5x - 18.7x | 16.0x |
| Fair Price | (93.57) - (117.60) | (109.22) |
| Upside | -7031.5% - -8811.4% | -8190.3% |
| Date | EV/EBITDA |